Oncotarget

Oncotarget · ISSN (e) 1949-2553 · 129 papers in corpus
observational 2014
doi:10.18632/oncotarget.1936 ·PMID:25127259

The events leading to breast cancer (BC) progression or recurrence are not completely understood and new prognostic markers aiming at identifying high risk-patients and to develop suitable therapy are highly demanded. Experimental evidences…

lab-animal 2014
doi:10.18632/oncotarget.2092 ·PMID:24979463

ARID1A mutations are observed in various tumors, including ovarian clear cell (OCCC) and endometrioid carcinomas, endometrial, and breast carcinomas. They commonly result in loss of ARID1A-protein expression and frequently co-occur with PI3…

lab-animal 2012
doi:10.18632/oncotarget.688 ·PMID:23211466

Overexpression of Shc adaptor proteins is associated with mitogenesis, carcinogenesis and metastasis. Multiple copies in T-cell malignancy 1 (MCT-1) oncoprotein promotes cell proliferation, survival and tumorigenic effects. Our current data…

other 2011
doi:10.18632/oncotarget.432 ·PMID:22267462

National Cancer Institute has announced 24 provocative questions on cancer. Here I try to answer some of them by linking the dots of existing knowledge.